Lidman: Intends to purchase 70% of the shares of Sinovac Xiangrui for 1.733 billion yuan.

Ledman announcement, the listed company will purchase Shanghai Baijiahui Investment Management Co., Ltd., Nanjing Baijiarui Enterprise Management Consulting Partnership Enterprise, and Hainan Xiansheng Baijiahui Technology Development Co., Ltd. by paying cash for their 70% shareholding in Xiansheng Xiangrui. The transaction price is 1.733 billion yuan. After the completion of this transaction, the listed company will hold 70% stake in Xiansheng Xiangrui, which will become a subsidiary of the listed company. Through this transaction, the listed company's operating income and net profit attributable to the parent company shareholders will be enhanced, the financial condition of the listed company will be further improved, and it will be beneficial to safeguard the interests of the listed company shareholders.